Literature DB >> 30897515

Malignant Phyllodes Tumors of the Breast: Association Between Race, Clinical Features, and Outcomes.

Ambria S Moten1, Amy J Goldberg2.   

Abstract

BACKGROUND: We sought to investigate associations between race, clinical characteristics, and outcomes among patients with malignant phyllodes of the breast.
METHODS: Malignant phyllodes cases were identified using Surveillance Epidemiology and End Results database. We used chi-square tests to compare characteristics between racial groups and multinomial logistic regression to calculate relative risk ratios (RRR) and 95% confidence intervals (CI) comparing the likelihood of having particular characteristics by race. Survival analyses included Cox regression and Kaplan-Meier functions.
RESULTS: Among 1202 patients included, mean age was 51.7 y and 55.2% were white. Compared to whites, blacks were younger (mean age 45.7 versus 55.1 y; P < 0.001), and more likely to have tumors 51-100 mm (RRR = 1.91; 95% CI: 1.20-3.05) and tumors > 100 mm (RRR = 2.52; 95% CI: 1.56-4.05) than tumors ≤ 50 mm in size. Compared to whites, Hispanics were younger (mean age 46.7 versus 55.1 y; P < 0.001), and more likely to have tumors 51-100 mm (RRR = 1.46; 95% CI: 1.01-2.11) than tumors ≤ 50 mm in size. Asians were more likely to have tumors 51-100 mm (RRR = 1.52; 95% CI: 1.01-2.30) and tumors > 100 mm (RRR = 1.61; 95% CI: 1.03-2.52) than tumors ≤ 50 mm in size, and more likely to have tumors that extended beyond the breast tissue (RRR = 1.87; 95% CI: 1.05-3.31), compared to whites. Survival was similar for blacks (HR = 1.48; 95% CI: 0.80-2.76), Hispanics (HR = 1.02; 95% CI: 0.54-1.93), and Asians (HR = 1.13; 95% CI: 0.63-2.01) compared to whites.
CONCLUSIONS: Further research into factors contributing to extensive disease at presentation among minorities is warranted.
Copyright © 2019 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Breast; Malignant; Outcomes; Phyllodes tumor; Race

Year:  2019        PMID: 30897515     DOI: 10.1016/j.jss.2019.01.054

Source DB:  PubMed          Journal:  J Surg Res        ISSN: 0022-4804            Impact factor:   2.192


  4 in total

1.  Malignant phyllodes tumor and primary breast sarcoma; distinct rare tumors of the breast.

Authors:  Lily Gutnik; Yi Ren; Samantha M Thomas; Jennifer K Plichta; Rachel A Greenup; Oluwadamilola M Fayanju; E Shelley Hwang; Laura H Rosenberger
Journal:  J Surg Oncol       Date:  2022-02-18       Impact factor: 3.454

2.  Genomic characteristics of two breast malignant phyllodes tumors during pregnancy and lactation identified through whole-exome sequencing.

Authors:  Tinge Lei; Mengjia Shen; Xu Deng; Yongqiang Shi; Yan Peng; Hui Wang; Tongbing Chen
Journal:  Orphanet J Rare Dis       Date:  2022-10-21       Impact factor: 4.303

3.  Preoperative interventional artery embolization for the treatment of a giant malignant phyllodes tumor: A case report.

Authors:  Yue Tian; Linlin Liu; Liang Chen; Shengdi Zhao; Ruijun Su; Wenzhu Zhang; Aimei Jiang; Wenlin Chen; Fei Ge
Journal:  Mol Clin Oncol       Date:  2021-05-11

4.  The treatment process of an extremely rare giant borderline phyllodes tumor of breast: case report and literature review.

Authors:  Qing Wang; Kai Zheng; Lei Zhang; Mingjian Tan; Hongwan Li; Hengyu Zhang; Dong Chen; Zhilin Li; Zhirui Chuan; Xi Wang; Yuanxiao Wang; Lei Zhe; Lijuan Liu; Dequan Liu; Rong Guo; Shicong Tang
Journal:  Transl Cancer Res       Date:  2021-04       Impact factor: 1.241

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.